Observational studyCanadian journal of anaesthesia = Journal canadien d'anesthesie2026
Phase-dependent agreement between noninvasive and invasive blood pressure monitoring during transcatheter aortic valve replacement: a prospective observational study.
Observational study in Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe aimed to evaluate the phase-dependent agreement between continuous noninvasive blood pressure monitoring using ClearSight™ (Edwards Lifesciences Corp., Irvine, CA, USA) and invasive arterial pressure (IAP) across distinct intraoperative phases of transcatheter aortic valve replacement (TAVR).
methodsWe conducted a single-centre observational study at a tertiary academic hospital performing TAVR. We included 21 patients undergoing TAVR, contributing 987 paired invasive and noninvasive blood pressure measurements. We recorded noninvasive blood pressure monitoring using ClearSight concurrently with standard IAP monitoring as part of routine clinical care. We analyzed repeated paired measurements using Bland-Altman methods extended with linear mixed-effects modeling, with additional sensitivity analyses performed to assess robustness.
resultsWe compared invasive and ClearSight-derived systolic, mean, and diastolic pressures. ClearSight underestimated systolic and mean pressures and overestimated diastolic pressure. After excluding outliers identified by quantile-quantile plot diagnostics, mean biases (IAP minus ClearSight) were +14 mm Hg (systolic), +6 mm Hg (mean), and -3 mm Hg (diastolic). Limits of agreement narrowed after outlier removal, and intraclass correlation coefficients improved (systolic, 0.69 to 0.72; mean, 0.65 to 0.68; diastolic, 0.59 to 0.63). Phase-specific analysis showed the widest disagreement during induction/stabilization, improved accuracy during valve deployment, and the best agreement, particularly for mean arterial pressure, after protamine administration, when vascular tone and hemodynamic stability were restored.
conclusionsClearSight showed phase-dependent agreement with IAP during TAVR, typically underestimating systolic and mean pressures, with improved agreement during hemodynamic stability, most notably after protamine. These findings support ClearSight as an adjunct rather than a replacement for invasive arterial monitoring during TAVR. Broader validation studies are warranted.
Indexed as
Identifiers
42681401What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.